Bioxytran's total assets for Q2 2025 were $147.50K, an increase of 8.42% from the previous quarter. BIXT total liabilities were $2.78M for the fiscal quarter, a -2.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.